Shortages of a popular prostate cancer therapy are giving a small drugmaker in Buffalo Grove an edge over giant north suburban rival AbbVie. Tolmar Pharmaceuticals' Eligard has long been up against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results